Patrick Henderson Joins Novoclem Therapeutics as Chief Financial Officer

By a News Reporter-Staff News Editor at Pharma Business Week — – Novoclem Therapeutics, a subsidiary of private life science technology company KNOW Bio, LLC, announced that Patrick K. Henderson has joined the company and will serve as Chief Financial Officer (see also Novoclem Therapeutics).

Henderson is a seasoned pharmaceutical finance leader with more than 20 years of experience, including 15 years in leadership roles with specialty pharmaceutical, health care, diagnostics and clinical research companies.

“As a proven financial professional, Patrick brings a wealth of experience and leadership to Novoclem at a critical time in our development,” said Anne Whitaker, CEO of Novoclem Therapeutics. “His deep knowledge will benefit us greatly as we trailblaze a new path to treat respiratory diseases.”

Henderson joins Novoclem from LabCorp where he served as Vice President, Finance for the past 20 months overseeing the financial planning and analysis processes for the global S&P 500 company. Prior to LabCorp, he served as Executive Director, Finance of Salix Pharmaceuticals, a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of gastrointestinal disorders, which was acquired by Valeant in April 2015 for $14 billion.

In 2005, Henderson joined Salix and helped build Salix’s finance organization, serving in various financial leadership roles of increasing responsibility over his 10-year tenure. He was appointed as Executive Director, Finance in 2012 and was responsible for overseeing Salix’s day-to-day financial activities. He has also held several financial leadership roles at Cigna Healthcare.

Henderson earned his MBA, Finance, from the University of Tennessee at Chattanooga, as well as two BS degrees – Accounting and Management.

Keywords for this news article include: Novoclem Therapeutics, Investment and Finance.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC